Introduction to Medullary Thyroid Cancer: Understanding the Disease
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. It is important to understand the basics of MTC in order to identify and properly treat the disease.
What is the thyroid?
The thyroid is a butterfly-shaped gland located in the front of the neck, just below the Adam’s apple. It produces hormones that regulate the body’s metabolism, including the rate at which the body burns calories and the rate at which the heart beats.
What are the types of thyroid cancer?
There are several types of thyroid cancer, including:
- Papillary thyroid cancer: This is the most common type of thyroid cancer and tends to grow slowly.
- Follicular thyroid cancer: This type of thyroid cancer is less common than papillary thyroid cancer and tends to grow more quickly.
- Medullary thyroid cancer: As mentioned earlier, MTC is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA.
- Anaplastic thyroid cancer: This is the most aggressive type of thyroid cancer and tends to grow quickly.
What are the causes of MTC?
- Familial: MTC is often inherited in an autosomal dominant manner. About 25% of MTC cases are caused by inherited mutations in the RET proto-oncogene.
- Sporadic: The remaining 75% of MTC cases are caused by new mutations in the RET proto-oncogene that occur spontaneously.
What are the symptoms of MTC?
Symptoms of MTC may include:
- Neck mass: This is the most common symptom of MTC.
- Hoarseness: This is caused by a mass pressing on the nerve to the larynx (voice box).
- Difficulty swallowing: This is caused by a mass pressing on the esophagus.
- Pain in the neck, throat, or jaw: This is caused by a mass pressing on nerves or blood vessels.
- Swollen lymph nodes: This is caused by cancer spreading to the lymph nodes.
MTC is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. It is important to understand the basics of MTC in order to identify and properly treat the disease. If you have symptoms that may be caused by MTC, it is important to see a doctor to get a proper diagnosis.
Symptoms and Diagnosis of Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. Understanding the symptoms and diagnosis process of MTC is important in order to properly identify and treat the disease.
Symptoms of MTC
Symptoms of MTC may include:
- Neck mass: This is the most common symptom of MTC.
- Hoarseness: This is caused by a mass pressing on the nerve to the larynx (voice box).
- Difficulty swallowing: This is caused by a mass pressing on the esophagus.
- Pain in the neck, throat, or jaw: This is caused by a mass pressing on nerves or blood vessels.
- Swollen lymph nodes: This is caused by cancer spreading to the lymph nodes.
It’s important to note that these symptoms can also be caused by other conditions and do not necessarily indicate MTC. If you have any of these symptoms, it is important to see a doctor to get a proper diagnosis.
Diagnosis of MTC
The process of diagnosing MTC typically involves the following steps:
Physical exam and medical history
During a physical exam, the doctor will check for any signs of MTC, such as a neck mass or swollen lymph nodes. The doctor will also take a detailed medical history to identify any risk factors for MTC.
Blood tests
Blood tests can be used to check for elevated levels of calcitonin and CEA, which are hormones produced by the cells in the thyroid that are affected by MTC.
Imaging tests
Imaging tests, such as ultrasound, CT scan, or MRI, can be used to create detailed images of the thyroid and surrounding areas. These images can help the doctor identify any suspicious masses or lymph nodes.
Biopsy
A biopsy is a procedure in which a small sample of tissue is taken from the suspicious mass or lymph node and examined under a microscope. A biopsy can confirm the presence of cancer cells and help determine the type of thyroid cancer.
Understanding the symptoms and diagnosis process of MTC is important in order to properly identify and treat the disease. If you have any symptoms that may be caused by MTC, it is important to see a doctor to get a proper diagnosis. With proper diagnosis and treatment, the prognosis for MTC can be quite good.
Risk Factors and Causes of Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. Knowing the risk factors and causes of MTC can help in the early detection and prevention of the disease.
Risk Factors
There are several known risk factors for MTC, including:
- Familial: MTC is often inherited in an autosomal dominant manner. About 25% of MTC cases are caused by inherited mutations in the RET proto-oncogene.
- Age: MTC is more common in older adults.
- Gender: MTC is more common in males.
- Race: MTC is more common in African Americans.
- Previous radiation exposure: People who have had radiation therapy to the head or neck have an increased risk of MTC.
Causes
The main causes of MTC are mutations in the RET proto-oncogene. This gene provides instructions for making a protein that helps regulate cell growth and division. In most cases, these mutations occur spontaneously, but in about 25% of cases, they are inherited in an autosomal dominant manner.
MTC is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. Knowing the risk factors and causes of MTC can help in the early detection and prevention of the disease. If you have any risk factors for MTC, it is important to discuss this with your doctor and consider genetic counseling. With early detection and proper treatment, the prognosis for MTC can be quite good.
Treatment Options for Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. Understanding the treatment options for MTC can help in the management of the disease.
Surgery
Surgery is the primary treatment for MTC. The goal of surgery is to remove the entire thyroid gland and any surrounding lymph nodes that contain cancer cells. This is known as a total thyroidectomy. In some cases, a lymph node dissection may also be performed to remove any nearby lymph nodes that contain cancer cells.
External radiation therapy
External radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells. This type of therapy is not commonly used to treat MTC, but may be considered in certain cases where surgery is not possible.
Medications
- Calcitonin: Calcitonin is a hormone that is produced by the cells in the thyroid affected by MTC. Elevated levels of calcitonin can be used as a marker for MTC.
- Somatostatin analogs: These medications can help to slow the growth of MTC by blocking the action of certain hormones that promote cell growth.
- Retinoic acid derivatives: These medications can help to slow the growth of MTC by blocking the action of certain proteins that promote cell growth.
- Targeted therapy: Targeted therapy uses drugs that target specific molecules involved in the growth and spread of cancer cells.
Treatment for MTC typically involves surgery to remove the entire thyroid gland and any surrounding lymph nodes that contain cancer cells, as well as medications to slow the growth of cancer cells. In some cases, external radiation therapy may also be considered. The treatment plan will be tailored to the individual case, taking into account the stage and grade of the cancer, as well as the patient’s overall health. With proper treatment, the prognosis for MTC can be quite good.
Prognosis and Prevention of Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that begins in the cells of the thyroid that produce and store hormones called calcitonin and CEA. Understanding the prognosis and prevention of MTC can help in the management of the disease.
Prognosis
The prognosis for MTC varies depending on the stage of the cancer at the time of diagnosis, as well as the patient’s overall health. In general, the prognosis is better for patients who are diagnosed with MTC at an early stage.
Overall, the 5-year survival rate for patients with MTC is about 85%. For patients with localized MTC (confined to the thyroid gland), the 5-year survival rate is about 95%. For patients with regional MTC (spread to nearby lymph nodes), the 5-year survival rate is about 80%. And for patients with distant MTC (spread to distant organs), the 5-year survival rate is about 50%.
Prevention
There is currently no known way to prevent MTC. However, there are certain measures that can be taken to reduce the risk of developing the disease.
-
Genetic counseling: If you have a family history of MTC or a genetic mutation that increases your risk of MTC, it is important to discuss this with your doctor and consider genetic counseling.
-
Regular check-ups: Regular check-ups with your doctor can help to detect MTC at an early stage, when it is most treatable.
-
Avoiding radiation exposure: Avoiding unnecessary radiation exposure can help to reduce the risk of developing MTC.
The prognosis for MTC is generally good when the cancer is diagnosed at an early stage. However, there is currently no known way to prevent MTC. Genetic counseling and regular check-ups can help in early detection, and avoiding unnecessary radiation exposure can help to reduce the risk of developing MTC. With proper treatment and follow-up care, patients with MTC can have a good quality of life.
Sources & references used in this article:
- Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma (A WellsSamuel Jr, L AsaSylvia, B EvansDouglas… – Thyroid, 2015 – liebertpub.com)
https://www.liebertpub.com/doi/fulltext/10.1089/thy.2014.0335 - Current approaches to medullary thyroid carcinoma, sporadic and familial (EA Fialkowski, JF Moley – Journal of surgical oncology, 2006 – Wiley Online Library)
https://onlinelibrary.wiley.com/doi/abs/10.1002/jso.20690 - RET proto oncogene mutation detection and medullary thyroid carcinoma prevention (MZ Yeganeh, S Sheikholeslami… – … of Cancer Prevention, 2015 – koreascience.or.kr)
https://www.koreascience.or.kr/article/JAKO201528551641812.pdf - Medullary thyroid cancer diagnosis: an appraisal (P Trimboli, L Giovanella, A Crescenzi… – Head & …, 2014 – Wiley Online Library)
https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.23449 - Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma (…, E Modigliani, TF Medullary Study Group – Clinical …, 2001 – Wiley Online Library)
https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2265.2001.01339.x - Management of medullary thyroid carcinoma (C Jiménez, I Mimi, N Hu, RF Gagel – Endocrinology and metabolism clinics …, 2008 – Elsevier)
https://www.sciencedirect.com/science/article/pii/S0889852908000133 - Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial (F Iten, B Müller, C Schindler, C Rochlitz, D Oertli… – Clinical Cancer …, 2007 – AACR)
https://aacrjournals.org/clincancerres/article-abstract/13/22/6696/13255 - Medullary thyroid cancer: management guidelines of the American Thyroid Association (RT Kloos, C Eng, DB Evans, GL Francis, RF Gagel… – Thyroid, 2009 – liebertpub.com)
https://www.liebertpub.com/doi/abs/10.1089/thy.2008.0403